Dr. Samuel D. Swisher-McClure, MD

Dr. Swisher-McClure practices at Beebe Healthcare in Lewes, Delaware, part of Beebe Medical Center.

Dr. Swisher-McClure's NPI, 1669675880, was assigned on June 6, 2007. Dr. Swisher-McClure graduated from Wayne State University School of Medicine in 2007. Dr. Swisher-McClure holds Delaware license C1-0024207.

Dr. Swisher-McClure's primary practice is Beebe Healthcare, at 424 Savannah Rd, Lewes, DE 19958 in Sussex County. The practice phone is (302) 645-3300.

Dr. Swisher-McClure's primary practice is Beebe Healthcare in Lewes, Delaware, part of Beebe Medical Center. Dr. Swisher-McClure is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Delmarva Radiation Services. Dmand AI also links Dr. Swisher-McClure to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swisher-McClure practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Swisher-McClure's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Swisher-McClure's licenses on file in 2 states: Delaware and Pennsylvania.

CMS data shows 3,747 Medicare services from Dr. Swisher-McClure across 21 procedure codes in 2024, for 477 Medicare patients. Medicare paid $252,980 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 477 Medicare patients who saw Dr. Swisher-McClure in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have cancer, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swisher-McClure's median patient age at 72, with 43% women.

In 2024, Dr. Swisher-McClure wrote 267 Medicare Part D claims for 116 patients. 96% of them were for generic drugs. CMS names the drug for 165 of them, across 5 drugs with 11 or more claims each, at $2,961 in total drug cost. In 2023, CMS named 100 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 52 out of 100 for Dr. Swisher-McClure for performance year 2024, reported individually. Dr. Swisher-McClure accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 58 papers to Dr. Swisher-McClure, published from 2011 to 2023. 2021 was the busiest year, with 9. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Oropharyngeal Neoplasms. Dr. Swisher-McClure has published most often in Int J Radiat Oncol Biol Phys. Dr. Swisher-McClure's most frequent co-authors are Alexander Lin, MD, John N. Lukens, MD and Gregory S. Weinstein, MD.

Dmand AI links Dr. Swisher-McClure to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 7 general payments to Dr. Swisher-McClure from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $95.

Dr. Swisher-McClure graduated from Wayne State University School of Medicine in 2007.